ArchivIA Università degli Studi di Catania
 

ArchivIA - Archivio istituzionale dell'Universita' di Catania >
Tesi >
Tesi di dottorato >
Area 05 - Scienze biologiche >

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10761/1036

Data: 24-feb-2012
Autori: Catania, Angela Maria
Titolo: Enhancement of efficacy and selectivity of chemopreventive compounds in human breast cancer cells by using immunoliposomes
Abstract: Trastuzumab targets the human epidermal growth factor receptor 2 (HER2), which is overexpressed in 20-30% of breast and ovarian cancers carrying a bad prognosis. Our purpose was to target HER2-overexpressing human breast cancer cells with pegylated immunoliposomes bearing trastuzumab and containing bioactive compounds. Using two breast cancer cell lines, with different HER2 expression levels, these immunoliposomes decreased cancer cells viability in a dose-response manner and in correlation to their level of HER2 expression.
InArea 05 - Scienze biologiche

Full text:

File Descrizione DimensioniFormatoConsultabilità
CTNNLM83B54B202Q-Tesi Angela Catania.pdfTesi Angela Catania3,84 MBAdobe PDFVisualizza/apri


Tutti i documenti archiviati in ArchivIA sono protetti da copyright. Tutti i diritti riservati.


Segnala questo record su
Del.icio.us

Citeulike

Connotea

Facebook

Stumble it!

reddit


 

  Browser supportati Firefox 3+, Internet Explorer 7+, Google Chrome, Safari

ICT Support, development & maintenance are provided by the AePIC team @ CILEA. Powered on DSpace Software.